{"id":"tablets-artemether-lumefantrine","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-15%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Artemether is a fast-acting antimalarial agent that rapidly kills the parasite, while lumefantrine is a slower-acting agent that helps to eliminate any remaining parasites. Together, they provide a synergistic effect in treating malaria.","oneSentence":"Artemether/lumefantrine works by targeting the malaria parasite's cell membrane and disrupting its function, ultimately leading to the parasite's death.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:20.480Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of uncomplicated malaria due to Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, and Plasmodium malariae"}]},"trialDetails":[{"nctId":"NCT07403643","phase":"PHASE4","title":"Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria","status":"NOT_YET_RECRUITING","sponsor":"Curtin University","startDate":"2026-04","conditions":"Uncomplicated Malaria","enrollment":60},{"nctId":"NCT06967519","phase":"PHASE4","title":"OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-12-18","conditions":"Malaria, Hiv","enrollment":380},{"nctId":"NCT05757167","phase":"PHASE4","title":"Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics","status":"RECRUITING","sponsor":"Duke University","startDate":"2023-11-06","conditions":"Malaria,Falciparum, Malaria in Pregnancy, Malaria in Childbirth","enrollment":2500},{"nctId":"NCT04300309","phase":"PHASE2, PHASE3","title":"Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-12-21","conditions":"Plasmodium Falciparum Malaria","enrollment":28},{"nctId":"NCT04009343","phase":"PHASE2, PHASE3","title":"Pharmacokinetics and Pharmacodynamics of the Gametocytocidal and Post-treatment Chemoprotective Effects of Antimalarials","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2019-06-19","conditions":"Uncomplicated Falciparum Malaria","enrollment":182},{"nctId":"NCT06962319","phase":"PHASE3","title":"Safety of Antimalarials in the FIRst trimEster","status":"RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2025-09-30","conditions":"Malaria, Pregnancy, Malaria, Antepartum, Malaria (Uncomplicated)","enrollment":1510},{"nctId":"NCT05951595","phase":"PHASE3","title":"A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-09-11","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":1680},{"nctId":"NCT03923725","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs.","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-09-01","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":2583},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":"Malaria","enrollment":870},{"nctId":"NCT05540470","phase":"NA","title":"Radical CUREfor MAlaria Among Highly Mobile and Hard-to-reach Populations in the Guyanese Shield","status":"COMPLETED","sponsor":"Centre Hospitalier de Cayenne","startDate":"2022-09-12","conditions":"Malaria, Vivax","enrollment":1991},{"nctId":"NCT05788094","phase":"PHASE4","title":"ACT vs CQ With Tafenoquine for P. Vivax Mono-infection","status":"RECRUITING","sponsor":"Shoklo Malaria Research Unit","startDate":"2023-06-26","conditions":"Malaria, Malaria, Vivax, Plasmodium Vivax Malaria","enrollment":606},{"nctId":"NCT06970600","phase":"NA","title":"Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2024-03-07","conditions":"Malaria (Uncomplicated)","enrollment":352},{"nctId":"NCT06516042","phase":"PHASE3","title":"Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia","status":"ACTIVE_NOT_RECRUITING","sponsor":"PATH","startDate":"2024-08-21","conditions":"Plasmodium Falciparum, Malaria","enrollment":10350},{"nctId":"NCT03453840","phase":"PHASE4","title":"Extended Duration Artemether-lumefantrine Treatment for Malaria in Children","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2018-02-21","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":305},{"nctId":"NCT06347471","phase":"PHASE4","title":"The Transmission of Artemisinin Resistant Parasites Before and After Conventional Artemisinin-combination Therapy","status":"RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-05-28","conditions":"Falciparum; Malaria","enrollment":120},{"nctId":"NCT04704999","phase":"PHASE4","title":"Southeast Asia Dose Optimization of Tafenoquine","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-07-22","conditions":"Plasmodium Vivax Malaria","enrollment":700},{"nctId":"NCT06294912","phase":"PHASE1","title":"A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-18","conditions":"Malaria","enrollment":16},{"nctId":"NCT06076213","phase":"PHASE4","title":"Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2023-05-01","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":1260},{"nctId":"NCT05550909","phase":"PHASE2","title":"Gametocytocidal and Transmission-blocking Efficacy of ASAQ and ALAQ With or Without PQ in Mali","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2022-10-17","conditions":"Malaria,Falciparum","enrollment":100},{"nctId":"NCT04546633","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-02-16","conditions":"Uncomplicated Plasmodium Falciparum Malaria","enrollment":295},{"nctId":"NCT01614964","phase":"PHASE2","title":"Studies of a Candidate Aminoquinoline Antimalarial (AQ-13)","status":"COMPLETED","sponsor":"Tulane University","startDate":"2013-08","conditions":"Malaria","enrollment":66},{"nctId":"NCT06300970","phase":"PHASE4","title":"Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2022-08-09","conditions":"Plasmodium Falciparum, Malaria, Uncomplicated Malaria","enrollment":352},{"nctId":"NCT04666350","phase":"","title":"Clinical Investigation Study to Evaluate the Consistency and Reproducibility of Two Consecutive Mosquito Feeding Assays","status":"COMPLETED","sponsor":"PATH","startDate":"2021-03-09","conditions":"Malaria","enrollment":42},{"nctId":"NCT04041973","phase":"NA","title":"Study to Assess Efficacy of Artemether-lumefantrine Prophylaxis Against Forest Malaria in Cambodia (PAL_Cambodia)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2020-03-11","conditions":"Malaria","enrollment":1480},{"nctId":"NCT03939104","phase":"PHASE3","title":"A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combinations of 2 Anti-malarial Drugs (Asia)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2021-06-30","conditions":"Plasmodium Falciparum Malaria (Uncomplicated)","enrollment":103},{"nctId":"NCT05958810","phase":"","title":"TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018","status":"COMPLETED","sponsor":"Research Institute for Tropical Medicine, Philippines","startDate":"2017-01-02","conditions":"Malaria,Falciparum, Malaria Recrudescence","enrollment":80},{"nctId":"NCT05958693","phase":"","title":"TES of Artemether-lumefantrine for Pf in the Philippines in 2015","status":"COMPLETED","sponsor":"Research Institute for Tropical Medicine, Philippines","startDate":"2015-01-05","conditions":"Malaria,Falciparum, Malaria Recrudescence","enrollment":82},{"nctId":"NCT04222088","phase":"","title":"TES of Artemether-lumefantrine for Pf and Chloroquine for Pv in the Philippines From 2013-2014","status":"COMPLETED","sponsor":"Research Institute for Tropical Medicine, Philippines","startDate":"2013-05-01","conditions":"Malaria, Falciparum Malaria, Vivax Malaria","enrollment":159},{"nctId":"NCT03813108","phase":"NA","title":"Safety and Efficacy of NF135 CPS Immunization","status":"TERMINATED","sponsor":"Radboud University Medical Center","startDate":"2019-04-01","conditions":"Malaria,Falciparum, Controlled Human Malaria Infection, Immunization; Infection","enrollment":43},{"nctId":"NCT05340153","phase":"PHASE4","title":"Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon","status":"UNKNOWN","sponsor":"University of Yaounde 1","startDate":"2022-04-11","conditions":"Malaria","enrollment":184},{"nctId":"NCT04897919","phase":"PHASE4","title":"Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2015-08-01","conditions":"Malaria, Effectiveness","enrollment":474},{"nctId":"NCT05192265","phase":"PHASE2, PHASE3","title":"Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine","status":"COMPLETED","sponsor":"University of Ibadan","startDate":"2019-05-20","conditions":"Malaria Fever, Plasmodium Falciparum Malaria, Uncomplicated Malaria","enrollment":172},{"nctId":"NCT04053907","phase":"NA","title":"P. Falciparum Infection Dynamics and Transmission to Inform Elimination","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2019-08-15","conditions":"Malaria","enrollment":4000},{"nctId":"NCT01054248","phase":"PHASE3","title":"Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2010-02-16","conditions":"Malaria","enrollment":511},{"nctId":"NCT03576313","phase":"PHASE3","title":"Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2018-08-11","conditions":"Malaria","enrollment":4939},{"nctId":"NCT03167242","phase":"PHASE2","title":"Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2017-08-02","conditions":"Acute Uncomplicated Plasmodium Falciparum Malaria","enrollment":524},{"nctId":"NCT04618523","phase":"PHASE4","title":"Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2020-10-26","conditions":"Malaria","enrollment":1117},{"nctId":"NCT05081089","phase":"PHASE2","title":"Gametocytocidal and Transmission-blocking Efficacy of PQ in Combination With AL and TQ in Combination With SPAQ in Mali","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2021-10-12","conditions":"Malaria,Falciparum","enrollment":80},{"nctId":"NCT00541385","phase":"PHASE3","title":"Pyronaridine Artesunate 3:1 Granule Formulation vs. Coartem© Crushed Tablets in P. Falciparum Malaria Pediatric Patients","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2007-10","conditions":"Malaria","enrollment":535},{"nctId":"NCT00422084","phase":"PHASE3","title":"Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2007-01","conditions":"Malaria","enrollment":1272},{"nctId":"NCT03199755","phase":"PHASE2","title":"Dried Leaf Artemisia (DLA) Compared to Artemisinin Combination Therapy (ACT) vs Malaria","status":"WITHDRAWN","sponsor":"Worcester Polytechnic Institute","startDate":"2018-08-20","conditions":"Malaria","enrollment":""},{"nctId":"NCT03452475","phase":"PHASE3","title":"Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2018-03-07","conditions":"Plasmodium Falciparum","enrollment":219},{"nctId":"NCT04310085","phase":"PHASE1","title":"Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2020-02-19","conditions":"Malaria,Falciparum, Parasitemia, Protozoan Infections","enrollment":16},{"nctId":"NCT03510481","phase":"PHASE1","title":"Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-05-14","conditions":"Malaria","enrollment":478},{"nctId":"NCT04877626","phase":"PHASE4","title":"Assessment of the Therapeutic Efficacy and Tolerability of the Artesunate/Amodiaquina Combination and Artemether/Lumefantrine Combination, Treatment of Uncomplicated P. Falciparum Malaria in the Department of Chocó (Colombia)","status":"COMPLETED","sponsor":"Universidad Nacional de Colombia","startDate":"2008-09","conditions":"P. Falciparum Malaria","enrollment":210},{"nctId":"NCT04829695","phase":"PHASE4","title":"Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon","status":"UNKNOWN","sponsor":"University of Yaounde 1","startDate":"2021-04-05","conditions":"Falciparum Malaria","enrollment":184},{"nctId":"NCT04565184","phase":"PHASE4","title":"Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2019-05-09","conditions":"Malaria,Falciparum","enrollment":242},{"nctId":"NCT04778813","phase":"PHASE4","title":"Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)","status":"UNKNOWN","sponsor":"Centre national de recherche et de formation sur le paludisme","startDate":"2021-06-01","conditions":"Malaria, Burkina Faso","enrollment":1050},{"nctId":"NCT04531072","phase":"PHASE4","title":"Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine","status":"COMPLETED","sponsor":"Fogarty International Center of the National Institute of Health","startDate":"2018-09-18","conditions":"Drug Interaction","enrollment":20},{"nctId":"NCT04370977","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children (MEFI_III)","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2018-03-21","conditions":"Malaria","enrollment":630},{"nctId":"NCT04020653","phase":"PHASE2","title":"A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria","status":"WITHDRAWN","sponsor":"Neopharma Japan Co., Ltd.","startDate":"2019-09-06","conditions":"Malaria","enrollment":""},{"nctId":"NCT02223871","phase":"PHASE1","title":"Effect of ACT-451840 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Subjects","status":"COMPLETED","sponsor":"Idorsia Pharmaceuticals Ltd.","startDate":"2014-06","conditions":"Healthy Subjects","enrollment":8},{"nctId":"NCT03764527","phase":"PHASE4","title":"Tolerability and Efficacy of Artemether-Lumefantrine Versus Artesunate + Amodiaquine in Zanzibar","status":"COMPLETED","sponsor":"Professor Anders Björkman","startDate":"2002-11-01","conditions":"Plasmodium Falciparum Malaria","enrollment":408},{"nctId":"NCT01845701","phase":"PHASE3","title":"Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon","status":"COMPLETED","sponsor":"University of Yaounde 1","startDate":"2010-03","conditions":"Malaria","enrollment":720},{"nctId":"NCT02020330","phase":"PHASE3","title":"Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2013-11-25","conditions":"Plasmodium Falciparum Infection","enrollment":150},{"nctId":"NCT03241901","phase":"PHASE4","title":"\"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania\"","status":"COMPLETED","sponsor":"Muhimbili University of Health and Allied Sciences","startDate":"2017-07-27","conditions":"Malaria,Falciparum","enrollment":280},{"nctId":"NCT01967472","phase":"NA","title":"Adherence to Antimalarial Drugs in Sierra Leone","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-09-16","conditions":"Malaria","enrollment":1145},{"nctId":"NCT02940756","phase":"PHASE4","title":"Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the Congo","status":"COMPLETED","sponsor":"Ministry of Public Health, Democratic Republic of the Congo","startDate":"2017-03-15","conditions":"Malaria","enrollment":1615},{"nctId":"NCT02184637","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-07-31","conditions":"Malaria, Vivax","enrollment":120},{"nctId":"NCT02001012","phase":"PHASE3","title":"P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine","status":"COMPLETED","sponsor":"Menzies School of Health Research","startDate":"2014-01","conditions":"Uncomplicated Knowlesi Malaria","enrollment":123},{"nctId":"NCT01976780","phase":"PHASE4","title":"In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy","status":"COMPLETED","sponsor":"Global Emerging Infections Surveillance and Response System","startDate":"2013-06","conditions":"Malaria","enrollment":118},{"nctId":"NCT02348788","phase":"PHASE3","title":"Artemether-lumefantrine vs Chloroquine for Uncomplicated P. Vivax Malaria in Malaysia","status":"UNKNOWN","sponsor":"Menzies School of Health Research","startDate":"2015-01","conditions":"Plasmodium Vivax Malaria Without Complication","enrollment":98},{"nctId":"NCT02528279","phase":"NA","title":"Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria","status":"COMPLETED","sponsor":"Albert Schweitzer Hospital","startDate":"2014-10","conditions":"Malaria","enrollment":50},{"nctId":"NCT02974348","phase":"PHASE3","title":"Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa","status":"COMPLETED","sponsor":"University of Bamenda","startDate":"2013-01","conditions":"Drug Resistant Malaria Due to Plasmodium Falciparum","enrollment":300},{"nctId":"NCT00694694","phase":"PHASE3","title":"Azithromycin + Artesunate v Artemether-lumefantrine in Uncomplicated Malaria.","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2008-06","conditions":"Malaria","enrollment":261},{"nctId":"NCT02741024","phase":"PHASE4","title":"Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR Congo","status":"COMPLETED","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2013-10","conditions":"Malaria","enrollment":288},{"nctId":"NCT00852423","phase":"PHASE3","title":"Safe and Efficacious Artemisinin-based Combination Treatments for African Pregnant Women With Malaria","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2010-06","conditions":"Malaria in Pregnancy","enrollment":3428},{"nctId":"NCT02662855","phase":"PHASE2","title":"Efficacy of Favipiravir Against Severe Ebola Virus Disease","status":"COMPLETED","sponsor":"Beijing Institute of Pharmacology and Toxicology","startDate":"2014-11","conditions":"Ebola Virus Disease","enrollment":77},{"nctId":"NCT02637128","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum Malaria","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2014-03","conditions":"MALARIA, FALCIPARUM","enrollment":452},{"nctId":"NCT02325180","phase":"PHASE4","title":"Artemisinin-based Combination Therapy for Treatment of Plasmodium Falciparum Malaria in North Sumatera, Indonesia","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2015-01","conditions":"Malaria, Falciparum","enrollment":338},{"nctId":"NCT01697787","phase":"PHASE4","title":"Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2012-10","conditions":"Malaria","enrollment":150},{"nctId":"NCT01619878","phase":"PHASE2, PHASE3","title":"Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-10","conditions":"Acute Uncomplicated Falciparum Malaria","enrollment":20},{"nctId":"NCT01374581","phase":"PHASE3","title":"Impact of Artemisinin-based Combination Therapy and Quinine on Treatment Failure and Resistance in Uncomplicated Malaria","status":"COMPLETED","sponsor":"Universiteit Antwerpen","startDate":"2012-05","conditions":"Malaria","enrollment":2117},{"nctId":"NCT00677833","phase":"PHASE2, PHASE3","title":"Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-06","conditions":"Malaria, Falciparum","enrollment":361},{"nctId":"NCT02168569","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2011-06","conditions":"Malaria","enrollment":700},{"nctId":"NCT01944189","phase":"PHASE4","title":"Artemether/ Lumefantrine: A Study of the Effect of Local Food on Pharmacokinetics and Population Pharmacokinetics","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2013-09","conditions":"Malaria, Falciparum","enrollment":70},{"nctId":"NCT02143934","phase":"PHASE4","title":"Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity","status":"COMPLETED","sponsor":"Papua New Guinea Institute of Medical Research","startDate":"2009-08","conditions":"Plasmodium Vivax Infection, Plasmodium Vivax Clinical Episode, Plasmodium Falciparum Infection","enrollment":524},{"nctId":"NCT01998295","phase":"PHASE4","title":"Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine","status":"COMPLETED","sponsor":"Muhimbili University of Health and Allied Sciences","startDate":"2012-05","conditions":"Instantaneous Clearance","enrollment":45},{"nctId":"NCT01256658","phase":"PHASE4","title":"A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)","status":"COMPLETED","sponsor":"Novartis","startDate":"2010-11","conditions":"Malaria","enrollment":14075},{"nctId":"NCT00393679","phase":"PHASE3","title":"Evaluation of 4 Artemisinin-based Combinations for Treating Uncomplicated Malaria in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2007-07","conditions":"Fever, Malaria","enrollment":4112},{"nctId":"NCT01939886","phase":"PHASE3","title":"Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2013-04","conditions":"Malaria","enrollment":219},{"nctId":"NCT00527800","phase":"PHASE3","title":"Interactions Between HIV and Malaria in African Children","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2007-08","conditions":"Malaria, HIV Infections","enrollment":351},{"nctId":"NCT01899820","phase":"PHASE3","title":"Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya","status":"UNKNOWN","sponsor":"Sabah Ahmed Omar","startDate":"2013-04","conditions":"Malaria","enrollment":2100},{"nctId":"NCT01876966","phase":"PHASE1","title":"Interaction Between Etravirine or Darunavir/Ritonavir and Artemether / Lumefantrine","status":"COMPLETED","sponsor":"Janssen Pharmaceutica N.V., Belgium","startDate":"2011-03","conditions":"HIV","enrollment":33},{"nctId":"NCT00697892","phase":"PHASE1","title":"Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations","status":"COMPLETED","sponsor":"Fran Aweeka","startDate":"2005-07","conditions":"HIV Infections, Malaria","enrollment":38},{"nctId":"NCT01043744","phase":"NA","title":"Non-malarial Febrile Illness in Children in Areas of Perennial Malaria Transmission","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2010-01","conditions":"Malaria, Non-malarial Febrile Illness","enrollment":1000},{"nctId":"NCT01625871","phase":"PHASE3","title":"Artemether/Lumefantrine and Vivax Malaria","status":"COMPLETED","sponsor":"University of Khartoum","startDate":"2011-09","conditions":"Vivax Malaria","enrollment":38},{"nctId":"NCT01599000","phase":"PHASE4","title":"Artemether-Lumefantrine Clinical Effectiveness Study","status":"COMPLETED","sponsor":"Papua New Guinea Institute of Medical Research","startDate":"2011-03","conditions":"Parasitologically Confirmed; Malarial","enrollment":159},{"nctId":"NCT01082731","phase":"PHASE4","title":"Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in Brazil","status":"TERMINATED","sponsor":"Centers for Disease Control and Prevention","startDate":"2010-11","conditions":"Malaria","enrollment":6},{"nctId":"NCT01107145","phase":"PHASE4","title":"Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)","status":"TERMINATED","sponsor":"Centers for Disease Control and Prevention","startDate":"2011-02","conditions":"Plasmodium Vivax Malaria","enrollment":16},{"nctId":"NCT01567423","phase":"NA","title":"Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Epicentre","startDate":"2008-04","conditions":"Malaria, Falciparum","enrollment":301},{"nctId":"NCT00720811","phase":"NA","title":"Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2009-10","conditions":"Malaria, Pneumonia","enrollment":6456},{"nctId":"NCT01082705","phase":"PHASE3","title":"Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2010-04","conditions":"P. Falciparum Malaria","enrollment":323},{"nctId":"NCT01055002","phase":"PHASE1, PHASE2","title":"A Pilot Study to Test Activity of Antimalarial Drugs Against an Induced Malaria Infection in Healthy Volunteers","status":"COMPLETED","sponsor":"Medicines for Malaria Venture","startDate":"2010-01","conditions":"Healthy, Non-smokers","enrollment":16},{"nctId":"NCT01103830","phase":"PHASE1","title":"Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers","status":"COMPLETED","sponsor":"sigma-tau i.f.r. S.p.A.","startDate":"2010-02","conditions":"Malaria, Falciparum","enrollment":287},{"nctId":"NCT00444106","phase":"PHASE4","title":"Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory Function","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-05","conditions":"Malaria, Falciparum","enrollment":265},{"nctId":"NCT00426439","phase":"PHASE4","title":"Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau","status":"COMPLETED","sponsor":"Bandim Health Project","startDate":"2006-12","conditions":"Malaria, Falciparum","enrollment":300},{"nctId":"NCT00619944","phase":"PHASE4","title":"Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir","status":"COMPLETED","sponsor":"Makerere University","startDate":"2008-02","conditions":"HIV Infections","enrollment":32},{"nctId":"NCT00620438","phase":"PHASE4","title":"Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2008-02","conditions":"HIV Infections, Tuberculosis","enrollment":90},{"nctId":"NCT01052584","phase":"NA","title":"Ethiopia Malaria Therapeutic Efficacy Study","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2009-10","conditions":"Malaria","enrollment":354}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":124,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Quartem"],"phase":"phase_3","status":"active","brandName":"tablets artemether/lumefantrine","genericName":"tablets artemether/lumefantrine","companyName":"University of Khartoum","companyId":"university-of-khartoum","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tablets of artemether/lumefantrine are used to treat malaria, specifically uncomplicated Plasmodium falciparum and Plasmodium vivax malaria. The exact mechanism of action of artemether/lumefantrine is unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}